kansas-bioscience-authority-kba-pays-received-usd400-000-to-pra-create-80-new-jobs

US state pays PRA $0.4 mn for creating jobs

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority (KBA) to create 80 new jobs this year... Read more

us-based-oncobiologics-and-china-based-zhejiang-huahai-pharma-are-looking-to-grab-a-chunk-of-the-global-usd40-billion-biosimilars-market

Huahai, Oncobiologics enter generics partnership

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for the development, manufacture and commercialization... Read more

quintiles-begins-trading-on-nyse-under-q-symbol

Quintiles begins trading on NYSE under 'Q' symbol

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Quintiles has made the pricing of its initial public offering (IPO) of 23,684,210 shares of its common stock at a price to the public of $40.00 per share.... Read more

us-fda-asks-pregnant-women-suffering-from-migraine-not-to-take-valproate-sodium-as-it-may-cause-decreased-iq-in-children

FDA: Pregnant women must not take migraine drug

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA is alerting healthcare providers and patients that medications including and related to valproate sodium can cause decreased intelligence quotient... Read more

ge-healthcare-s-new-fraction-collector-and-sample-pump-will-enhance-automation-of-kta-pure-protein-purification-system

GE launches new pump for protein purification

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare has launched a flexible fraction collector and robust and intelligent sample pump that is specifically designed to enhance ÄKTA pure, the... Read more

china-botanic-pharma-delisted-from-new-york-stock-exchange-for-noncompliance

NYSE delists China Botanic Pharma

  • China
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: China Botanic Pharmaceutical received a notice from the NYSE due to its noncompliance with the plan that was previously submitted by the company on February... Read more

even-those-non-diabetic-individuals-who-have-high-blood-sugar-are-prone-to-alzheimer-s

High blood sugar causes Alzheimer’s in non-diabetics

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by the University of Arizona (UA), US, highlighted that elevated blood sugar levels are linked to risk for developing Alzheimer's disease.... Read more

bayer-healthcare-stops-phase-ii-trial-of-haemophilia-a-and-b-drug-bay-86-6150-after-detecting-neutralizing-antibody-led

Bayer stops haemophilia trial amidst drug safety concern...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety... Read more

good-news-for-sleep-apnea-patients-fisher-paykel-launches-its-next-generation-flow-generator-range-f-p-icon

F&P ICON+ flow generator to treat sleep apnea better

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fisher & Paykel Healthcare has introduced F&P ICON+, the next generation of its flow generator range for use in the treatment of obstructive sleep apnea... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X